Survey of CBG Users Higher Learning LV Podcast
-
- Careers
In No. 20 of the Cannabis Commerce + Chemistry Podcast, host Curt Robbins from Higher Learning LV and co-hosts John Bailey from the Mindset Genesis in Las Vegas and Dena Putnam from Leafwize Naturals in Orange County, California discuss an October 2022 research study about the cannabinoid cannabigerol, or CBG. This fast-paced roundtable teaches listeners about the potential health and wellness benefits of CBG and popular commercial products that offer this phytomolecule.
Bailey, Putnam, and Robbins discuss the ways in which CBG may help those who consume it, including reductions in anxiety, depression, and chronic pain and potential improvements for sleep disorders. They discuss the results and industry ramifications of the study, including how the majority of those surveyed considered their use of CBG to be beneficial, with minimal side effects (unlike THC). The group compares and contrasts CBG with cannabidiol, or CBD and tetrahydrocannabinol, or THC.
This weekly 30-minute podcast is targeted at cannabis and hemp industry professionals and is strategically free of profanity and crude dialog. This audio session was edited for length and clarity. To better understand the potential outcomes of use of CBG and the market opportunities presented by this cannabinoid, listen now.
Visit sponsor Higher Learning LV at https://HigherLearningLV.co/blog.
Follow Higher Learning LV on Facebook at https://bit.ly/3w6Dyf7.
In No. 20 of the Cannabis Commerce + Chemistry Podcast, host Curt Robbins from Higher Learning LV and co-hosts John Bailey from the Mindset Genesis in Las Vegas and Dena Putnam from Leafwize Naturals in Orange County, California discuss an October 2022 research study about the cannabinoid cannabigerol, or CBG. This fast-paced roundtable teaches listeners about the potential health and wellness benefits of CBG and popular commercial products that offer this phytomolecule.
Bailey, Putnam, and Robbins discuss the ways in which CBG may help those who consume it, including reductions in anxiety, depression, and chronic pain and potential improvements for sleep disorders. They discuss the results and industry ramifications of the study, including how the majority of those surveyed considered their use of CBG to be beneficial, with minimal side effects (unlike THC). The group compares and contrasts CBG with cannabidiol, or CBD and tetrahydrocannabinol, or THC.
This weekly 30-minute podcast is targeted at cannabis and hemp industry professionals and is strategically free of profanity and crude dialog. This audio session was edited for length and clarity. To better understand the potential outcomes of use of CBG and the market opportunities presented by this cannabinoid, listen now.
Visit sponsor Higher Learning LV at https://HigherLearningLV.co/blog.
Follow Higher Learning LV on Facebook at https://bit.ly/3w6Dyf7.